跳至主要内容
临床试验/NCT06700317
NCT06700317尚未招募不适用

Intraoperative Hyperspectral Imaging for Laparoscopic Surgery (LapHSI): a Multicentre Post-market Clinical Study

King's College London0 个研究点目标入组 40 人开始时间: 2025年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
主要终点
Device safety

研究概览

简要总结

The study aims to evaluate the use of the HyperSnap Surgical System (HSS1) during laparoscopic surgeries, specifically in bowel resections and cholecystectomies.

详细描述

The study will observe patients undergoing bowel resection and cholecystectomy surgeries to determine if HyperSnap Surgical System (HSS1), as a primary visualisation tool, functions safely and capably as a laparoscopic imager. In addition, we will see if it subjectively improves the identification of critical anatomical structures. In addition, the study will secondarily assess how StO2 information may be included in the surgical workflow and how surgeons may react to this additional information.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A) Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy)
  • Adult patients aged 18 years and over
  • Common bile duct diameter < 8mm as assessed using ultrasound
  • Patients able to provide written informed consent
  • B) Colorectal cancer requiring elective bowel resection via a laparoscopic approach.
  • Adult patients aged 18 years and over
  • Patients who are scheduled for elective laparoscopic colon cancer resection
  • Patients able to provide written informed consent

排除标准

  • A) Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy)
  • Patients under 18 years of age
  • Patients with a history of previous abdominal surgery and multiply scarred abdomen
  • Common bile duct diameter ≥ 8mm as assessed using ultrasound
  • Patients unable to provide written informed consent
  • Patients who are pregnant
  • B) Colorectal cancer requiring elective bowel resection via a laparoscopic approach.
  • Patients under 18 years of age
  • Patients with a history of previous abdominal surgery and multiply scarred abdomen
  • Patients unable to provide written informed consent
  • Patients undergoing emergency surgery
  • Patients who are pregnant

结局指标

主要结局

Device safety

时间窗: From enrollment to end of follow up (30 days)

To demonstrate that under normal conditions of use, the performance characteristics of the device are those intended, enabling laparoscopic abdominal surgery to be safely performed using the UKCA-marked medical device (HSS1) as the primary surgical visualisation system.

次要结局

  • Technological performance(Duration of surgery)
  • Utility and usability of tissue oxygenation saturation maps in bowel surgery(Duration of surgery)
  • Utility and usability of tissue oxygenation saturation maps in cholecystectomy(Duration of surgery)
  • Human factors analysis on use of HSS1(Duration of surgery)

研究者

申办方类型
Other
责任方
Sponsor

相似试验